Joseph Martinko compensation by year
Chemours Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $473,333 | $542,123 |
| Bonus | — | $0 |
| Stock awards | $356,135 | $425,281 |
| Option awards | $327,708 | $367,408 |
| Non-equity incentive | $251,370 | $301,568 |
| Pension and deferred compensation | $0 | $0 |
| All other | $24,500 | $32,327 |
| Total | $1,433,046 | $1,668,707 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Chemours Co DEF 14A filed March 10, 2026, accession 0001104659-26-025935, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Chemours Co filed document, accession 0001104659-26-025935. Every figure is read from that document and cited to the page and table it appears in. Filed March 10, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 13,437 | $158,422 | — |
| PSU | 13,437 | $158,422 | — |
| PSU | 6,369 | $75,091 | — |
| RSU | 3,939 | $46,441 | — |
| RSU | 1,718 | $20,255 | — |
| RSU | 550 | $6,485 | — |
| Option | 44,664 | — | $13.86 |
| Option | 46,451 | — | $15.25 |
| Option | 10,959 | — | $30.25 |
| Option | 10,538 | — | $27.50 |
| Option | 1,248 | — | $34.84 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Chemours Co's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
2 Form 4 lines since the FY2025 proxy (filed March 10, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-07 | Purchase | — | 1,939.8 | $15.47 | 55,431.4 |
| 2026-08-01 | Tax withholding | — | 663 | $16.61 | 54,818.56 |
The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Chemours discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Death | $0 | $465,116 | $0 | $902,616 |
| Voluntary resignation | — | — | — | $0 |
| Change in control and involuntary termination | $1,615,000 | $592,987 | $46,730 | $3,210,817 |
| Disability | $0 | $465,116 | $0 | $902,616 |
| Change in control, no termination | $0 | $465,116 | $0 | $465,116 |
| Involuntary termination without cause | $1,062,500 | $0 | $23,365 | $1,387,433 |
| Retirement | — | — | — | $0 |
Per the Potential Payments Upon Termination or Change in Control table in Chemours Co's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Chemours’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Denise Dignam | President and Chief Executive Officer | $8,595,076 |
| Shane Hostetter | Senior Vice President, Chief Financial Officer | $2,746,166 |
| Kristine Wellman | Senior Vice President, General Counsel and Corporate Secretary | $1,958,806 |
| Joseph Martinko · this page | President, Thermal and Specialized Solutions | $1,668,707 |
| Gerardo Familiar | President, Advanced Performance Materials | $1,532,835 |
Joseph Martinko's compensation dossier, Chemours
You have read Joseph Martinko's totals and holdings. The dossier adds each equity grant Chemours disclosed for Joseph Martinko and Chemours's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Chemours compensation record
free company briefThis page is one person within Chemours's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Chemours proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Chemours's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Chemours's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CC
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.